Ozempic & Mounjaro
for PCOS in India
GLP-1 medications tackle PCOS at its root — insulin resistance. Significant weight loss, lower testosterone, restored periods, reduced acne and hirsutism. Supervised by Dr. Manuj Sondhi, MRCP UK, Nirvana Clinic, Greater Noida.
Why Ozempic & Mounjaro Work for PCOS
PCOS (Polycystic Ovary Syndrome) is the most common hormonal disorder in women of reproductive age — affecting 1 in 5–10 Indian women. At its core, PCOS is a metabolic disease driven by insulin resistance. Elevated insulin stimulates the ovaries to overproduce androgens (male hormones like testosterone), which disrupts ovulation, causes irregular periods, triggers acne, hirsutism (excess hair), and makes weight loss extremely difficult.
This is exactly where GLP-1 medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) intervene. By dramatically improving insulin sensitivity, they reduce the hormonal cascade that drives PCOS symptoms. The results go far beyond simple weight loss — though significant weight loss itself also helps restore ovulation and hormonal balance.
In 2023, semaglutide was formally added to international PCOS treatment guidelines. A 2024 meta-analysis found GLP-1 medications in PCOS patients produced significant reductions in BMI, waist circumference, testosterone, and HOMA-IR (insulin resistance index). Tirzepatide produced an average of −17.60 kg weight loss in PCOS women, followed by semaglutide at −11.85 kg.
In India, GLP-1 use in PCOS increased 7-fold between 2021 and 2025 (from 2.4% to 17.6% of PCOS patients). With generic semaglutide now available from ₹1,290/month following the March 2026 patent expiry, GLP-1 therapy for PCOS is now accessible to the vast majority of Indian patients for the first time.
"PCOS is fundamentally a metabolic disorder — not just a gynaecological one. When I correct insulin resistance with GLP-1 therapy, patients don't just lose weight. Their periods regularise, their testosterone drops, their acne clears, and often — after years of struggling — they feel like themselves again."— Dr. Manuj Sondhi, MRCP UK, Metabolic Specialist, Nirvana Clinic, Greater Noida
How GLP-1 Medications Fix PCOS at the Root
GLP-1 drugs don't just cause weight loss — they correct the hormonal cascade that drives every PCOS symptom.
GLP-1 medications improve how cells respond to insulin, reducing blood insulin levels. Since high insulin directly stimulates ovarian testosterone production, lowering insulin lowers testosterone — addressing PCOS at its hormonal root, not just treating symptoms.
As insulin resistance improves, the ovaries produce less androgen. Studies show semaglutide and tirzepatide significantly reduce total testosterone and free androgen index in women with PCOS — leading to visible improvements in acne, hair thinning, and hirsutism within 3–6 months.
By correcting insulin resistance and enabling weight loss, ovulation often resumes. Many women with PCOS report regular periods returning for the first time in years — even with just 5–10% weight loss. This is one of the most clinically significant outcomes of GLP-1 therapy in PCOS.
What Changes with GLP-1 Treatment for PCOS
Based on published meta-analyses and clinical trials in women with PCOS.
Semaglutide: avg −11.85kg · Tirzepatide: avg −17.60kg in PCOS patients (meta-analysis, ScienceDirect 2024). Even 5% weight loss begins to restore ovulation.
Significant reduction in total testosterone and free androgen index. GLP-1 medications reduce androgen production at source — the ovaries — by lowering insulin.
Many women with irregular or absent cycles report period regularisation within 3–6 months of GLP-1 therapy alongside weight loss. Ovulation resumes, improving fertility prospects.
As testosterone drops, androgen-driven acne — the stubborn, deep, hormonal type that doesn't respond to skincare — significantly improves. Most patients see results by month 3–4.
Unwanted facial and body hair growth slows as androgens decline. Hair that is already grown won't disappear, but new growth slows — a clinically measurable improvement over 6–12 months.
Meta-analysis showed −5.16cm waist reduction with GLP-1 therapy in PCOS women. Abdominal fat specifically drives insulin resistance — targeting it breaks the PCOS cycle.
GLP-1 treatment improves triglycerides, LDL cholesterol, and blood pressure — reducing the long-term cardiovascular risk that comes with PCOS and insulin resistance.
Women with PCOS often struggle with carbohydrate cravings driven by insulin spikes. GLP-1 medications directly reduce appetite and food-reward signalling, making the eating changes required for PCOS far more sustainable.
Semaglutide vs Mounjaro — Which for PCOS?
Both work well for PCOS. The choice depends on BMI, severity of insulin resistance, and budget.
(Ozempic / Wegovy / Generics)
(Mounjaro)
What You Must Know Before Starting
How We Treat PCOS at Nirvana Clinic
Blood tests: testosterone, DHEA-S, LH/FSH ratio, AMH, HbA1c, HOMA-IR, lipids, thyroid. Clinical exam and menstrual history. Confirm PCOS diagnosis and severity.
Select between semaglutide (generic/branded) or tirzepatide based on BMI, insulin resistance severity, fertility timeline, and budget. Prescription issued.
Dose titration with monthly reviews. Track weight, hormonal markers, period regularisation, acne improvement. Adjust dose and lifestyle plan based on response.
At target outcomes — structured maintenance plan. For patients wanting to conceive — planned medication stop 2 months before, with metabolic anchoring to preserve improvements.
Learn More About GLP-1 Treatments at Nirvana Clinic
Tirzepatide — India's most effective weight loss injection. ₹14,000–₹25,781/month. Full pricing, eligibility, and clinical trial data.
Read Mounjaro guide →Wegovy vs generics — from ₹1,290/month. Which brand to choose, how they compare to Mounjaro, and STEP-1 trial data.
Read Wegovy guide →40+ brand comparison — Natco, Alkem, Zydus, Sun Pharma, Dr. Reddy's. Dr. Manuj's prescribing recommendations for April 2026.
Read price guide →PCOS & GLP-1 — Frequently Asked Questions
QCan Ozempic or Mounjaro be used for PCOS in India?▼
Yes. GLP-1 medications including semaglutide (Ozempic, Wegovy, generics) and tirzepatide (Mounjaro) are used under medical supervision for PCOS management in India. Semaglutide was added to international PCOS treatment guidelines in 2023. These medications address the root cause — insulin resistance — while producing significant weight loss, lower testosterone, and restored menstrual cycles.
QHow does Ozempic help with PCOS specifically?▼
Ozempic improves insulin sensitivity, reducing blood insulin levels. Since high insulin drives ovarian androgen overproduction, lower insulin means lower testosterone. This leads to regular menstrual cycles, reduced acne, less hirsutism, and significant weight loss — particularly abdominal fat. Meta-analysis shows GLP-1 therapy reduces waist circumference by −5.16cm and total testosterone in PCOS patients.
QIs Mounjaro better than Ozempic for PCOS?▼
A 2024 meta-analysis found tirzepatide produced −17.60kg weight loss in PCOS patients vs −11.85kg for semaglutide. Mounjaro's dual GIP+GLP-1 mechanism may provide superior insulin resistance correction. However, generic semaglutide is now available from ₹1,290/month vs Mounjaro at ₹14,000/month. For most PCOS patients, semaglutide generics offer excellent value. Mounjaro is preferred for BMI >35 or severe insulin resistance.
QCan GLP-1 treatment help me get pregnant if I have PCOS?▼
GLP-1 therapy can indirectly improve fertility by restoring ovulation through weight loss and improved insulin sensitivity. Many women report regular periods returning — a prerequisite for natural conception. However, GLP-1 medications must be stopped at least 2 months before attempting conception. They are not safe during pregnancy. Dr. Manuj will plan a fertility-safe treatment timeline if conception is your goal.
QHow long does it take to see results in PCOS?▼
Most patients begin seeing metabolic changes within 8–12 weeks — improved energy, reduced cravings, early weight loss. Period regularisation typically occurs within 3–6 months. Acne and hirsutism improvements are slower — 4–6 months for acne, 6–12 months for hirsutism (existing hair growth doesn't reverse, but new growth slows). Hormonal marker improvements on blood tests are usually visible by the 3-month review.
QWhat is the cost of GLP-1 treatment for PCOS in India?▼
With generic semaglutide available from ₹1,290/month (Natco Semanat) or ₹1,800/month (Alkem Semasize pen) since March 2026, GLP-1 therapy for PCOS is now affordable for most patients. Mounjaro (tirzepatide) costs ₹14,000–₹25,781/month. Branded Wegovy is ₹10,850–₹16,400/month. Dr. Manuj will recommend the most appropriate option for your profile and budget.
QDoes Dr. Manuj treat PCOS in Greater Noida?▼
Yes. Dr. Manuj Sondhi (MRCP UK) at Nirvana Clinic, Shop GF-93, Sun Twilight Mall, opposite Delta 1 Metro Station, Greater Noida treats women with PCOS and metabolic conditions including insulin resistance, obesity, and hormonal imbalance. He prescribes GLP-1 medications as part of a comprehensive metabolic treatment plan. Call or WhatsApp +91 8800262767.
QIs an online consultation available for PCOS treatment?▼
Yes. Dr. Manuj offers video consultations for PCOS patients across Delhi NCR, India, and internationally. Initial blood tests will need to be done locally, but follow-up consultations, dose adjustments, and monitoring can be conducted online. WhatsApp +91 8800262767 to arrange.
Start GLP-1 Treatment for PCOS — Greater Noida
Sun Twilight Mall
Opp. Delta 1 Metro Station
Greater Noida, UP 201308
9:00 AM – 8:00 PM
Sunday — Closed
Same-day appointments available
Finally — A PCOS Treatment That Tackles the Root Cause
GLP-1 therapy for PCOS · From ₹1,290/month · Supervised by Dr. Manuj Sondhi MRCP UK
Restores periods · Reduces testosterone · Clears acne · Significant weight loss